Specialized physician in radiation oncology serves as an expert witness with more than 40 years of experience in cancer biology and the treatment of lymphoma, including over 30 years of litigation consultation, deposition, and courtroom testimony in oncology-related matters. Their work focuses on the clinical application of radiation therapy in hematologic malignancies, with particular emphasis on Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, and cutaneous lymphoma, as well as related conditions such as mycosis fungoides, leukemia, and plasmacytoma.

Their practice encompasses several key areas within radiation oncology and cancer biology. Central to their work is the therapeutic use of radiation in lymphoid malignancies, including total body irradiation, total lymphoid irradiation associated with radioimmunosuppression, and integration with bone marrow transplantation protocols. Their experience also includes evaluation of disease progression, treatment response, and complications arising in complex oncologic cases involving immune and hematologic systems. Their background in cancer biology further supports analysis of tumor behavior, treatment mechanisms, and clinical decision-making in radiation-based therapies.

Their professional experience reflects long-standing involvement in affiliated cancer treatment and research programs, with sustained work in lymphoma-related clinical and research initiatives, multidisciplinary cancer care efforts, and participation in national oncology studies and collaborative treatment protocols. Their contributions also extend to development of clinical guidance and evaluation frameworks through involvement with organizations such as the American College of Radiology and other oncology-focused professional groups, including participation in committees addressing radiation therapy practices and lymphoma treatment approaches.

Their qualifications include a Doctor of Medicine. Board certification is held in Radiation Oncology by the American Board of Radiology, and professional involvement includes participation in the American College of Radiology and other national oncology organizations, reflecting engagement in clinical standards, guideline development, and radiation oncology practices relevant to lymphoma and related malignancies.